Dr. Christopher J. Schultz, MD

Dr. Schultz practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Schultz's NPI, 1487606273, was assigned on May 17, 2006. Dr. Schultz graduated from Medical College Of Wisconsin in 1985. Dr. Schultz's Wisconsin license number on file is 30081.

Dr. Schultz's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Schultz's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Schultz is board certified in radiation oncology by the American Board of Radiology. Dr. Schultz has a license on file in Wisconsin.

Dmand AI lists bone cancer radiation and brain cancer radiation among the conditions Dr. Schultz treats.

CMS data shows 22 Medicare services from Dr. Schultz across 1 procedure code in 2023, all of them office visits, for 21 Medicare patients. Medicare paid $1,468 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Schultz in 2024. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 57, with 13% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Schultz for performance year 2024, reported as part of a group. Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 89 papers to Dr. Schultz, published from 2006 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Brain Neoplasms, Head and Neck Neoplasms and Carcinoma, Squamous Cell. Dr. Schultz has published most often in Int J Radiat Oncol Biol Phys. Dr. Schultz's most frequent co-authors are Minesh P. Mehta, MD, Joseph Anthony Bovi, MD and Musaddiq Javvad Awan, MD.

Dmand AI links Dr. Schultz to 4 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Salivary Gland Neoplasms, Squamous Cell Carcinoma of Head and Neck and Thyroid Carcinoma, Anaplastic. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 76 general payments to Dr. Schultz from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 78% of the total. Elekta, Inc. paid the most, $13,785.

Dmand AI lists 4 awards for Dr. Schultz, most recently Best Doctors in America in 2017.

Dr. Schultz graduated from Medical College Of Wisconsin in 1985. Dr. Schultz is a member of ASCO.

Dr. Schultz is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.